Education
About Us
Working with TipRanks
Follow Us
NanoViricides (NNVC)
XASE:NNVC
NNVC Stock Chart & Stats
$1.25
-$0.10(-6.54%)
At close: 4:00 PM EST
$1.25
-$0.10(-6.54%)
Day’s Range― - ―
52-Week Range$0.94 - $2.23
Previous CloseN/A
Volume409.80K
Average Volume (3M)143.34K
Market Cap
$26.74M
Enterprise Value$16.71M
Total Cash (Recent Filing)$1.13M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Nov 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding21,568,430
10 Day Avg. Volume199,739
30 Day Avg. Volume143,335
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.82
Price to Sales (P/S)0.00
P/FCF Ratio-2.48
Enterprise Value/Market Cap0.62
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-32.14
Enterprise Value/Ebitda-2.24
Forecast
1Y Price Target
$6.00Price Target Upside380.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NanoViricides News
NNVC FAQ
What was NanoViricides’s price range in the past 12 months?
NanoViricides lowest stock price was $0.94 and its highest was $2.23 in the past 12 months.
What is NanoViricides’s market cap?
NanoViricides’s market cap is $26.74M.
When is NanoViricides’s upcoming earnings report date?
NanoViricides’s upcoming earnings report date is Nov 23, 2026 which is in 337 days.
How were NanoViricides’s earnings last quarter?
NanoViricides released its earnings results on Nov 24, 2025. The company reported -$0.135 earnings per share for the quarter, beating the consensus estimate of -$0.18 by $0.045.
Is NanoViricides overvalued?
According to Wall Street analysts NanoViricides’s price is currently Undervalued.
Does NanoViricides pay dividends?
NanoViricides does not currently pay dividends.
What is NanoViricides’s EPS estimate?
NanoViricides’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoViricides have?
NanoViricides has 21,568,430 shares outstanding.
What happened to NanoViricides’s price movement after its last earnings report?
NanoViricides reported an EPS of -$0.135 in its last earnings report, beating expectations of -$0.18. Following the earnings report the stock price went down -2.362%.
Which hedge fund is a major shareholder of NanoViricides?
Currently, no hedge funds are holding shares in NNVC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NanoViricides
NanoViricides, Inc. is a development-stage company engaged in creating nanotechnology-based antiviral therapeutics. Its primary focus is on the research and development of drugs to combat viral infections by utilizing a novel platform that deploys nanomaterials to specifically target and neutralize viruses. The company operates in the biotechnology and pharmaceuticals sector, aiming to address unmet medical needs for treatments against viral diseases such as influenza, HIV, and COVID-19.
NNVC Stock 12 Month Forecast
Average Price Target
$6.00
▲(380.00% Upside)
Technical Analysis
CASI Pharmaceuticals
―
Enlivex
―
Akari Therapeutics
―
Moleculin Biotech
―
SAB Biotherapeutics
―
Ownership Overview
5.85%
Insiders
3.76% Mutual Funds
0.55% Other Institutional Investors
87.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---